Latest Members


Medicon Valley Alliance is continually adding new life science companies and organisations as members.

These companies and organisations have decided to join forces and strengthen their ties within the region, thereby anhancing their visibility with national and international companies looking at life science in Medicon Valley.

Below is a list of the companies that have recently joined the Medicon Valley Alliance!

Take a look and see if one of them is your new business partner. If you wish to view a directory of all companies and organisations in Medicon Valley – click here!

Latest Members


chart Biotech

chart biotech´s ambition is to contribute to a strong and sustainable Biotechnology industry. They do this through their services to companies of all sizes and guises, helping them chart a way forward and reach their development goals. chart Biotech operates within the following areas: corporate and business development strategy, product portfolio, stakeholder strategy and strategic network building.

Their current portfolio of projects includes the following areas: bioproduction, natural products, drug delivery, medical technology/devices that incorporate sensors.



RTC is a leading CRO in Europe with more than 40 years of experience providing high quality in nonclinical research to national and international pharmaceutical companies and health-related organizations. RTC has been fully accredited by AAALAC. The company offers a full range of experimental and consultancy services, performed by experts in the development and safety assessment of: Pharmaceuticals (Small molecules, Biologicals), Medical Devices, Veterinary Drugs, Food Products (Novel Food, Food Additives and Food Ingredients), Chemicals, Agrochemicals, Biocides. For each class of products, studies are performed according to international guidelines and regulations. RTC high standard quality is guaranteed through European, American and Japanese authorities’ approval.


eVision Industry Software creates best-in-class Control of Work software. Innovative solutions that improve the way companies like Shell, Total, BP, Statoil, RasGas, and many others operate on a global and local scale. eVision enables you to increase the safety and speed of hazardous operations, supporting you in reaching your operational excellence and safety objectives. With offices worldwide and partnerships with the world’s leading system integrators, eVision provides high-quality delivery and support, on location, at all times. 


 Daiichi Sankyo

Daiichi Sankyo and its 15,000 employees in more than 20 countries are dedicated to the creation and supply of innovative pharmaceutical products. In addition to a strong portfolio of medicines for hypertension and thrombotic disorders, the Group’s 2025 vision is to become a “Global Pharma Innovator with Competitive Advantage in Oncology”. The European headquarters are in Munich, Germany and we have affiliates in 12 European countries.  



Santax Medico

Santax Nordic is service-level company in Copenhagen and supports our activities in Denmark and Sweden (Norway and Finland). Santax Medico is concerned with medtech manufacturers and help them establish themselves in the Nordic Market. We perform; Marketing, Sales and Service for international Med-Tech companies. Our main suppliers are from USA, Japan, Germany, China, Sweden and Denmark.

AFYX Therapeutics

AFYX Therapeutics is changing the way mucosal diseases are treated. AFYX Therapeuticsis  a topical drug delivery company developing a pipeline of targeted treatments for conditions that currently lack approved therapy options.

Their proprietary Rivelin® patch is flexible, biodegradable, and adhesive to mucosal surfaces. Designed with electrospinning technology, it delivers a therapeutic directly to the site in need, without interfering with patients’ daily activities.

Rivelin patches are compatible with a multitude of active pharmaceuticals, fueling our pipeline of products that seek to deliver relief through targeted, continuous therapeutic delivery to mucosal tissue. Their  lead program, Rivelin-CLO, is in late-stage clinical trials for oral lichen planus, a condition that affects more than 6 million people.

Led by a global team that has brought seven new topical products to market, AFYX Therapeutics is creating a new treatment paradigm for mucosal diseases by providing the first medicines that stick.

Thyrolytics AB

Thyrolytics is developing a first-of-its-kind diagnostic device for thyroid disorders. Their technology implies a one-step direct measurement  of the serum levels of free T4 and T3 at efficient cost, short time and is assembled in a bench-top device format.


Resanitec offers comprehensive clean room and biosafety cabinet testing, certification and related services including environmental monitoring, airflow, HEPA filter integrity, Particle level, air exchange rate and clean room training.

Resanitec has vast experience in cleanroom systems in order to help ensure these critical areas are performing in accordance with international standards and customer quality specifications. Resanitec cleanroom testing and certification services are executed in accordance with Standard Operating Procedures (SOPs), in compliance with current Good Manufacturing Practices (cGMPs) and International Organization for Standardization (ISO). All samples are analyzed at own microbiology laboratory at the Ideon Science Park in Lund.


Technia Transcat AB 

TechniaTranscat is a global leading knowledge company within PLM. With offices all over the world, they are just as much a global system integrator as a local partner. The commitment to there clients continues to be delivered by engineers who have both detailed engineering expertise and an extensive understanding of the PLM solutions and different Industries.

With a long experience of working with companies within the Life Sciences Industry. They have the awareness about the challenges in the Life Sciences industry; a constant search for new ways to reduce time to market, decrease launch time of new products, streamline processes, make the packaging process less complex, increase revenues and cut cost and at the same time meet regulatory demands.

TechniaTranscats expertise is to help companies to drastically reduce product development costs and deliver products to market much faster than the competition – while enabling you to meet regulatory compliance – through smart use of Product Lifecycle Management (PLM) systems.

They have 600 consultants that are experts in ENOVIA®, CATIA®, SIMULIA®, BIOVIA® and DELMIA®, and have experience from working with over 5000 clients worldwide, many of them listed on the Fortune 500. TechniaTranscat is a part of Addnode Group, listed at the Nasdaq OMX Nordic List.



HalioDx is an immuno-oncology diagnostic company providing services to guide cancer care and contribute to precision medicine in the era of immuno-oncology and combination therapies.

Thanks to the pioneering work of Jérôme Galon, HalioDx provides a unique range of immune scoring solutions based on the analysis and the understanding of the immune contexture of tumor, a key determinant of patients’ outcomes and response to cancer treatment.

Conducted in a Research or GCP/GCLP environment, the HalioDx Clinical Research tests are now part of cancer Immunogram, a multi-parameter approach that offers a personalized and dynamic “fingerprint” of tumor-immune system interaction.

HalioDx has an experienced team of more than 130 employees, a CLIA-certified laboratory and compliant facilities to develop, manufacture, register and market in vitro diagnostic (IVD) products. HalioDx executes biomarker studies and companion diagnostic assay development in conformity with regulations and in partnership with biopharmaceutical companies.


Shenzhen Bao‘an Traditional Chinese Medicine Hospital Group

Shenzhen Bao’an Traditional Chinese Medicine Hospital Group is a well-established medical institution that includes a general hospital (Shenzhen Bao’an TCM hospital), a branch hospital (Acupuncture and Rehabilitation Hospital) and 13 community health service centers. The group aims to build a modern traditional Chinese hospital with a tertiary network of Chinese medicine and a hierarchical medical system. The group plans to have a general hospital, 5 branch hospitals and 50 community health service centers in the future.

After 30 years development, the general hospital of the group has become a Third-level grade-A TCM hospital that possesses the functions of medical care, science research, education, preventive medicine, health care and rehabilitation. Now, it has developed as the Guangdong Famous TCM Hospital, National standardized training base for resident doctors of Traditional Chinese, National standardized training base for resident doctors of General Medicine, Guangdong and Shenzhen Postdoctoral Innovation Practice Base, Guangdong Chest Pain Center and ShenZhen Stroke Center.


Phase Holographic Imaging AB

Phase Holographic Imaging AB (PHI) provides researchers in academia and the life sciences industry with products for live-cell kinetic studies. PHI’s time-lapse cytometer, the HoloMonitor® system, is based on our core technology holographic microscopy.

Since introducing the first instrument in 2011, PHI now offers a range of products for the label-free, long-term quantitative analysis of living cell dynamics, circumventing the drawbacks of traditional methods requiring toxic stains. Headquartered in Lund, Sweden, PHI trades through a network of international distributors.



Quintiles and IMS Health have come together to become IQVIA, The Human Data Science Company™

IQVIA commits to providing solutions that enable life sciences companies to innovate with confidence, maximize their opportunities and ultimately drive human health outcomes forward.

IQVIA provides actionable solutions by tapping into the power of the IQVIA CORE™:

  • Domain Expertise. Institutional knowledge and domain expertise across diseases, geographies and scientific methods
  • Advanced Analytics. Faster, more precise decision-making generated by advanced analytics designed for healthcare
  • Unparalleled Data. One of the world’s largest curated healthcare data sources with innovative privacy protections
  • Transformative Technology. Leading technologies to provide real-time access to operations-critical information

 IQVIA has approximately 50,000 employees working in offices in more than 100 countries. We have offices in all four Nordic countries with approximately 450 employees who help authorities, interest groups, pharmacies, hospitals, and companies in the pharmaceutical industry and medtech to gain new insights and in-depth knowledge.



GN Resound

GN Hearing A/S is part of the GN Group, a global leader in intelligent audio solutions that let you hear more, do more and be more than you ever thought possible. Our unique portfolio of medical solutions – and the deep research & development expertise behind this range of products gives our brands unprecedented advantages in the med-tech, hearables and intelligent audio field. Every day, we transform lives through the power of sound with Smart Hearing aids that enhance the lives of people with hearing loss to be more productive.

With world leading expertise in the human ear, sound, wireless technology and miniaturization, GN’s innovative products are marketed via our various brands and solutions to users in more than 90 countries across the world under the ReSound, Beltone and Interton brand names.

Founded in 1869, the GN Group today has 5,400 employees and its parent company, GN Store Nord, is listed on NASDAQ Copenhagen (GN.CO).



Redoxis is a Swedish CRO with a core competence and experience in preclinical models for autoimmune and inflammatory conditions. We provide a wide range of in vivo and in vitro models validated with standard reference therapies. Our models are excellent tools for investigation of therapeutic efficacy and MoA of novel therapies.

Redoxis performs tailor-made preclinical studies combining dedication, experience and agility to provide reliable results to your project.

Potter Clarkson LLP

Potter Clarkson LLP is an award-winning, top-tier firm of European patent and trade mark attorneys and IP lawyers, and one of the largest full service intellectual property practices in Europe.

Advising clients around the globe on intellectual property rights across a variety of industry and technical sectors, we are well-known for handling some of the most complex and challenging patent and trade mark cases, and are particularly well-regarded for our successful prosecution, opposition and appeal work.

Our proven excellence and commercial expertise has made us the European firm of choice for several global giants, household names, universities and SMEs, as well as smaller companies and individuals all of whom wish to benefit commercially from their investment into intellectual property. Furthermore, we can assist with all international IP issues through our associations with top attorney firms worldwide.

Originating in Nottingham, Potter Clarkson also has offices in London, Munich, Copenhagen, Stockholm and Lund. We have worked with companies in Scandinavia for over 30 years, and the office in Copenhagen, alongside the office facility in Lund, enables us to offer our full services within the Medicon Valley region.

In terms of Life Sciences, we operate one of the largest departments in Europe, with more than 35 specialists working in our Biotechnology and Pharmaceuticals group. As well as being a highly-respected firm of traditional patent and trade mark attorneys, many recognised as leaders in their field, the firm’s Dispute Resolution and Commercial team offers the full range of IP litigation services in all English courts of law, as well as all non-contentious, commercial legal services associated with IP.

Our goal is to work closely and strategically with our clients to ensure that they gain the most commercial benefit from their investment in IP.  


Scandion Oncology


Omron Electronics A/S

McNeil AB


Albright Life Sciences A/S 

Albright Life Sciences A/S is a top-tier and AAA rated executive search and leadership consulting company, and one of the largest Life Science-focused executive search firms in the Nordic region. We serve global- and local clients within the Life Science industry – delivering tailor-made solutions sensitive to their specialization, their organization and the specific challenges they are faced with.

As a founding member of Global Life Science Alliance (GLSA) and member of AESC (Association of Executive Search Consultants), Albright is governed by the highest standards and has a global reach of more than 70+ countries.

Albright is built on a single ambition: ‘To search, assess and recruit high caliber executives to the Life Science industry who are capable of generating significant competitive advantages to our clients’. We achieve this by delivering unparalleled and highly specialized industry expertise, comprehensive local market knowledge, and global reach capabilities. 

ReceptorPharma AB

ReceptorPharma is a young orphan receptor drug discovery company that is developing new drug candidates for neurodegenerative disorders, by utilizing recent discoveries in the expanding field of orphan G Protein-Coupled Receptor (GPCR) pharmacology and combining them with new knowledge into neurodegenerative disease mechanisms.

Our long-term goal is to create new medicines for many more disease states, using the therapeutically underutilized family of orphan GPCRs as drug targets. Literature searches suggest that 80% of all orphan GPCRs, of which there still are about 80-100 in the human genome, are strongly correlated to disease. This makes them highly interesting to us and we consider them the drug targets of tomorrow.


Mercodia – when accuracy matters

Mercodia provides biomarker immunoassays and services for clinical and research applications, notably within diabetes, obesity and cardiovascular disease. We service a global market of over 100 countries with immunoassays spanning nine different species, covering both the basic and clinical research sector.

Mercodia – immunoassays and services

Mercodia also offers GLP-compliant outsourcing services for preclinical and clinical studies. Our bioanalytical, development, and production services are guided by industry guidelines, an extensive quality system (MAQS) and ISO 13485 for manufacturing medical devices. We specialize in large molecule ligand-binding assays, PK/ADA/PD/TK analysis, and offer a unique expertise in product life cycle management.

  • Market-leading quality immunoassays (
  • Offers custom development and production
  • Excellent track-record in optimization of customer assays
  • Experts in bioanalysis and validation (FDA/EMA – PK/ADA/PD/RUO)


Eurofins Amatsigroup

Eurofins Amatsigroup is a leading international Contract Development and Manufacturing Organization (CDMO) based in Europe. Our company focuses on drug product development for chemical/biological entities and drug substance development for biologics.

We support small and major biopharmaceutical companies in an innovative way to help them achieving their (pre)clinical milestones timely.

Our solid track record in developing and manufacturing New Biological Entities (NBE)/New Chemical Entities (NCE) is one of our strongest asset.

We are experts in breakthrough technologies for highly potent compounds, poorly soluble drugs, lyophilisation processes and specific therapeutic areas (immunotherapies, orphan drugs, pediatric dosage forms…). Our facilities are perfectly designed for small clinical and/or commercial batches either for sterile or non-sterile dosage forms.

Involved in the earliest steps, our highly-qualified project management team will propose a complete drug development strategy in compliance with regulations.

Frequent communication through one single point of contact, flexibility, troubleshooting mindset, customized solutions, will help our clients to speed up their drug development process.

Our goal is to build a sustainable partnership with our customers to support their drug development pathway.

Eurofins Amatsigroup: your CDMO partner for full drug development on innovative molecules.


Our services:


Preclinical and early clinical development

Clinical and small scale manufacturing (GMP)

Clinical trial material (packaging & logistics)

Global project management ǀ CMC – RA


Contact us:


Lyhne life

Lyhne life is part of the advertising- and communication agency lyhne & co. The agency has 27 years of experience within marketing, strategy and communication.  We consist of 15 dedicated employees as well as freelance consultants.

Lyhne life is specialised in B2B communication to medtech, biotech and pharma companies.




Miltenyi Biotec

Miltenyi Biotec, is committed to empowering scientific discovery and impacting human lives. For more than 25 years, Miltenyi Biotec has played an essential role in the biomedical research and cellular therapy community. Their innovative tools support research at every level, from basic research to translational research to clinical application. Used by scientists and clinicians around the world, Miltenyi Biotec´s integrated technologies cover techniques of sample preparation, cell isolation, cell sorting, flow cytometry, cell culture, molecular analysis, and preclinical imaging. Their expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. Today, Miltenyi Biotec has 2,000 employees in 25 countries.”



NGT-Partners is a private equity company that invests in Life-science companies with a strong and untapped value proposition for the Chinese market and with the potential to become innovation leaders in China.


Var2 Pharmaceuticals 

VAR2 Pharmaceuticals is a privately held biotechnology company engaged in the design and development of proprietary therapeutic proteins targeting cancer-specific carbohydrate structures for multiple cancer indications. We have a portfolio of proteins with unique affinity and specificity for these cancer-associated carbohydrates for the development of treatments for cancers where there is no effective therapy, such as sarcoma, triple negative breast cancers and prostate cancer.

VAR2 is also engaged in the development of cancer diagnostics, through its subsidiary VarCT Diagnostics.

Both the therapeutic as well as diagnostic technologies are based on groundbreaking discoveries made by researchers at University of Copenhagen, Denmark, in collaboration with partners at University of British Columbia, Canada.


Novozymes is a global biotechnology company headquartered in Bagsværd outside of Copenhagen, Denmark.  The company has operations in a number of countries around the world, including China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. The Novozymes class A share capital is held by Novo A/S, a wholly owned subsidiary of the Novo Nordisk Foundation. Class B shares of its stock are listed on the NASDAQ OMX Nordic exchange.

Novozymes is a world leader within research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. 





Life Science Academy – EasyB, deals with technical and scientific trainings and conferences for professionals involved in the discovery, development, and life cycle management of pharmaceuticals, medical devices, and related medical products. LS Academy, with its experience, provides a complete range of quality services dedicated to the pharmaceutical and CRO industry.

Life Science Academy offers an excellent expertise in the planning and organization of medical and scientific meetings with the collaboration of both national and international experts. LS Academy is a leader in its sector and offers its clients the necessary skills for continuous professional development, ensuring a competitive advantage

Sofus Regulatory Affairs AB 

As of January 2017, Sofus is a part of Xendo.

 Sofus was founded in 2002 and is the leading Nordic regulatory consultancy, supplying comprehensive regulatory, quality and safety solutions, to both multinational corporations and small businesses in the Nordics and in Europe. Xendo was founded in 1990 and is a leading consultancy and project management organisation in the life science, pharmaceutical and healthcare fields.

When the leading Nordic regulatory experts join forces with a leading consultancy and project management organisation, exciting things happen for our clients.

 From discovery to market

Together, Sofus and Xendo have established a unique and strong offer within Drug Development, Regulatory affairs and Quality Assurance. Our combined expertise enables a complete scope of consultancy services for your product’s life cycle.

Our consultants have extensive experience from managing global projects within drug development and regulatory affairs, as well as product portfolios for local markets.

In all stages through development and maintenance we offer expert services – assisting companies to live up to all requirements and being one step ahead when placing and keeping their products on the market.

We are used to collaborating with big pharma as well as small companies with the same dedication and accuracy.



Vectorbuilder is the world’s leading provider of vector construction and virus packaging services through its highly innovative online interactive platform To date, we have delivered over 110,000 vectors. 

VectorBuilder at a glance:

  • Free to use
  • 114,732 vectors delivered to date
  • 85 different types of vector backbones (Always expanding)
  • Expansive databases of vector components: promoters, ORFs, epitope tags, shRNAs and gRNAs.
  • 100% sequence guarantee
  • High quality downstream virus packaging, BAC modification, shRNA and gRNA library construction
  • Free design tool and/or click on ‘Send Design Request’ for more complex vectors
  • Rich annotation of vectors
  • Highly affordable price: typically, a fraction of what it would cost you to do it yourself (starting at 70GBP)
  • Rapid turnaround: within days





We are an innovative engineering consultancy dedicated to assist and manage projects within Manufacturing in the Life Science Industry. Our high calibre, well-trained team can provide customer-orientated solutions, whilst dealing with real-life constraints. The company fundamentals are based upon a good understanding of pharmaceutical/biotech manufacturing processes, quality assurance and technology transfer. Our main competency areas are Project Management, Consulting, Process Engineering, GMP Manufacturing Equipment, Medical Devices, Assembly and Packaging.


Patient Enrollment Service – fast delivery, motivated patients and cost-efficient services. Pay only per eligible patient.

Patiro is a patient enrollment service provider that offers a full-service patient enrollment solution with performance-based terms.

Our proven approach is inspired by data-driven efforts which allow us to reach, engage and communicate with patients and in turn deliver highly motivated patients in time. Our service is compliant with all relevant regulation, including the upcoming GDPR.


PCG Clinical Services

PCG Clinical Services is a Scandinavian full-service CRO committed to improving clinical trials through our scientific expertise, progressive technology and more effective ways of working. Our capabilities range from early study advice through Phase I to Phase IV trials including complete biometrics services supported by our flexible global partner network.As master users of Viedoc™, our cutting-edge, world-class EDC tool, we’ll provide effortless eCRF set-up and give you complete control of your study. Our highly qualified people have been trusted by some of the most advanced drug developers to manage studies across extensive therapeutic areas.




Acesion Pharma ApS is a Danish biotech company founded in 2011 and based in Copenhagen. Acesion Pharma develops more efficacious and safe drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia.


Immunahr AB was founded in Lund 2012 with the aim to develop AhR (aryl hydrocarbon receptor) agonists for the treatment of immune-related disorders, e.g. autoimmune diseases, and cancer. The most advanced project focuses on patent protected AhR-active metabolites of the clinical compounds laquinimod and tasquinimod. Research is driven by collaborations with external partners in academia and the pharmaceutical industry.

Methyl Detect


With a staff of more than 500 (290+ lawyers) employees, Kammeradvokaten/ Poul Schmith has grown to be one of Denmark’s largest and leading full-service law firms. The biotech team of of advisors is composed of specialists across our specialist teams in, inter alia, corporate/M&A, regulatory affairs, compliance and litigation. Consequently, Kammeradvokaten is able to provide highly specialised advice in all legal areas in relation to the biotech industry based on in-depth knowledge of the commercial reality in which the players in this industry operate.

Truly Labs – Your Preclinical Lab Partner

Truly Labs is a preclinical CRO providing tailor-made in vitro and in vivo services. Our services span from biomarker analysis to fully integrated pharmacology programs.

The in vivo team can support you with e.g. pharmacokinetic (PK) studies and customized efficacy (PD) models, PK/PD relationships and dose predictions, as well as in vivo imaging and state of the art inhalation services. Our in vitro capabilities include a wide range of cell-based assays, including Mode-of-Action and efficacy assays, biomarker analysis, genotyping, and proteomics.
We are flexible, committed and accommodate our customers’ needs. Some use Truly Labs as their internal lab while others benefit from our capabilities in specific studies.

Study design, performance, data evaluation, and reporting – with extensive knowledge and experience in drug development we can support the progression of your projects.

Bone Support AB
Our Vision is to be the world leader in the development and commercialization of injectable bio-ceramic composites that have both first-in-class bone remodeling and drug-eluting capabilities, for the management of bone voids and associated complications.
Our Mission is to improve the lives of patients suffering from bone disorders that cause bone voids, lead to injury, breakage, pain, and reduced quality of life.

AstraZeneca, Gothenburg

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection.

Our Gothenburg site is one of AstraZeneca’s three global strategic science centres. The teams located here have broad scientific expertise and capabilities, and work across the entire value chain of research and development with internal colleagues from other sites as well as academic and industry partners from all over the world.

Leymus Genomics

Leymus Genomics offers industry leading products and services for genomic analyses (NGS) for the Nordic countries and Germany. We are based in Copenhagen and founded and operated by employees coming from the NGS and Diagnostic industry.

Our core business areas:

NGS and Microarray service lab

We run samples in partnership with GenomeScan; ISO/IEC 17025 accredited leader in DNA analysis from sample to bioinformatics report. Illumina, PacBio and 10X platform validated service, industry leading turnaround time down to one week, and price competitive. Assays include transcriptomics, epigenetics, single cell sequencing, whole exome and full genome sequencing.

Large scale on site data storage for HPC

We offer data storage in partnership with DDN.

Approximately half of all large genomics centres globally use Data Direct Networks (DDN) as their main data storage provider for sequencing applications, genomic pipelines and data collaboration solutions. We also provide large scale data storage for big data microscopy and systems biology.

Next Generation Sequencing library preparation

Leymus Genomics works with the company BioDynami, focusing on high-quality libraries, with industry leading short and simple library preparation time, minimizing hands on time.


SenzaGen is a spin out company from Lund University with expertise in immunology, technology and genomics. SenzaGen markets, sells and performs the in vitro GARD sensitization test through its own laboratory and through licenced CROs.

As a scientific quality-orientated and innovative international company, SenzaGen supports its clients with stringent quality assessments. The GARD test is recommended by ECHA and accepted by OECD for validation.


Immunicum is developing novel immuno-oncology therapies against a range of solid tumors. The approach is based on allogeneic dendritic cells that are designed to stimulate a personalized anti-tumor immune response in each patient. The Company’s lead compound, ilixadencel is currently being evaluated in clinical trials for the treatment of kidney cancer, liver cancer and gastrointestinal stromal tumors.


Link Logistics is a 100% Danish owned company with more than 15 years of experience in the courier transport business. Link Logistics offers globally integrated supply chain solutions within all types of transport. As the largest broker in Denmark, within the top 3 in Scandinavia, we are able to offer competitive rates to our customers. Link Logistics is a selected partner of some of the leading global courier companies, such as UPS, DHL and FedEx.

Link Logistics offers a flexible customer focused business concept which includes dimension measuring and weighing of all consignments. Focusing on easy-to-use IT solutions, Link Logistics continuously strives to improve and offer state-of-the-art IT integrated online booking site.

High security and quality
We offer door to door solutions worldwide through a carefully selected network of global partners. We ensure that your shipments arrive on time and keeps the right temperature along the way.

Please see our website for more information or contact Jonas Bay Kaas, Pharma Manager by mail: or phone + 45 3043 3773


Christians Hansen Health & Nutrition develop and produce products for dietary supplements, pharmaceuticals, infant formula and animal feed. Their key offering is probiotic cultures with documented effect for animals, humans and plants.


Ballerup is a leading municipality for business. It has Greater Copenhagen’s highest concentration of companies and jobs outside of Copenhagen itself. Greater Copenhagen is an area of interregional collaboration, bringing together the Capital Region of Denmark, Region Zealand and Skåne.
We have a diverse and strong business sector, featuring a unique mix of business types.






“ELPRO Nordic ApS, located in Roskilde west of Copenhagen, supports customers in Denmark, Sweden, Finland and Norway. ELPRO Nordic is a full affiliate of ELPRO-BUCHS AG Switzerland, an ISO 9001:2008 company with ISO 17025 accreditation for calibrations. ELPRO, founded in 1986, is a globally acting Swiss provider of innovative monitoring solutions specifically designed for the highly-regulated pharmaceutical, life science and healthcare industries. As a leader in these fields, ELPRO is a ‘full service’ organization offering state-of-the-art data loggers and indicators; stand-alone monitoring systems, cloud SaaS software platforms including data analytics; and a team of validation engineers to support technology integration into your business processes.

To best serve our customers, our staff is technically trained to provide application-based recommendations. As a result, we offer more than just a product, we provide turnkey solutions. Our specialist supports requests of all sizes – from monitoring just one piece of equipment to global all-inclusive projects requiring cold chain monitoring, thermal mapping, and facility monitoring systems. Whether you need an off-the-shelf product or a custom solution, our technical staff and nationwide sales team fully support you through the entire process of product recommendation, training, and implementation.

Please see our website for more information: or contact Søren Helmer Nielsen, General Manager by mail: or phone + 45 2220 2620”

ELPRO – we prove it.




AMMACE Consulting AB

Emmace Consulting offers excellence in advising and performance testing of pharmaceutical products on a CRO-basis.


ImmuneBiotech AB discovers and develops novel microbiome therapeutics based on probiotic lactic acid bacteria and synbiotic formulations targeting the gut microbiota and the immune system.

Link Medical Research

Link Medical Research was founded in Norway in 1995. Since then we have grown to become one of the largest Full Service CROs with offices in Copenhagen, Oslo, Stockholm, Malmö and Berlin. We have Project Leaders, CRAs, CTAs, Statisticians, Data Managers, Pharmacovigilance Managers, Regulatory Managers, Medical Writers, Medical Advisors, Medical Device Experts, Health Economists and Quality Assurance Managers in house.

Link Medical Research was founded in Norway in 1995. Since then we have grown to become one of the largest Full Service CROs with offices in Copenhagen, Oslo, Stockholm, Malmö and Berlin.

We specialize in:

  • Running Phase I-II trials for small and mid-size Companies
  • In and outsourcing of Regulatory Services
  • Oncology Services from Pre-Clinical to exit
  • Running late Phase trials for large Pharma Companies- Medical Device Services
  • Insourcing of Staff

Please see our website for more information: or contact Jan Hellqvist, Managing Director on or by phone +46709135125

Gedea Biotech

Gedea Biotech develops antibiotic-free and safe local treatments of bacterial and fungal infections. Gedea Biotech’s substance, GA101, is a natural substance that has always been part of our environment and is approved as a food additive. It acts by a novel mechanism that prevents and treats infection in depth by inhibiting the formation of biofilm. Due to the novel mode of action it has a reduced risk of inducing treatment resistance. The first product will be a slow-release pessary for treatment and prevention of vaginal fungal infections to be market launched in 2019/2020 as an OTC.


Follicum develops drugs that can both stimulate and inhibit hair follicle activity.
Independent in-vitro and in-vivo studies on living human skin tissue show that Follicum’s candidate drug is effective in inhibiting hair growth, while exhibiting no side effects.
In comparable in vivo studies in mice, one of Follicum’s drug candidates stimulated hair growth significantly faster, and produce hair growth over a much larger area than minoxidil (the active ingredient in Rogaine®).




ICONOVO is a Swedish privately funded device company with a business model to supply the market with unique, safe and cost efficient inhalation products. ICONOVO has long and unique experience and capability in the development of inhalation devices and formulations. ICONOVO’s products combine technical complexity with user friendly and attractive design. ICONOVO’s ambition is to become a leading supplier on a global market.



SOLVE is a CRO specialized in material characterisation.

We have world-leading competence in separation and characterization methods, for example the state-of-the-art technique asymmetric flow field-flow fractionation. This technique is highly suitable for standard and challenging materials and can provide superior additional/complementary information to conventional techniques.

We have experience in analysing non-biological materials such as plastics, metals as well as peptides, macromolecules, aggregates, formulation excipients, polysaccharides, emulsions, and more – assessing properties such as molar mass, composition, surface chemistry, shape etc.


At Speximo we have created a technique derived from nature that enable water-oil emulsion without the use of surfactants or synthetic emulsifiers.

Our patented technology is the result of international collaborations and applied research based on the exceptional Pickering particle properties of quinoa. We can now provide the cosmetic, food, and pharmaceutical industry with an environmentally sustainable mechanism for emulsion stabilization (EQMULSE), or encapsulation of active ingredients (EQLIPSE). The end-product is proven safe for sensitive skin and delivers a smooth, silky texture with a non-residual feeling. In our laboratory, our dedicated team continuously explore new applications and solve formulation problems for customers all over the world.


SmiLe is a life science business incubator based in Medicon Village in Lund, Sweden, that offers business development services to entrepreneurs to help them develop and commercialize their ideas. The incubator offers a unique infrastructure with well-equipped laboratories – cell and bacterial culturing, protein purification, chemical and biochemical analyses, in total at 1,700 m2 area – and operates in an environment of life science companies in various phases of development, with a variety of experts and investors. SmiLe receives basic funding from Region Skåne, Lund Municipality, Lund University and Medicon Village.

  • Facts about SmiLe companies:
  • SmiLe’s incubator and alumni companies have together attracted more than SEK 1,000 million in venture capital since 2014.
  • There are currently almost 25 companies at SmiLe that together have about 100 employees from 17 different nations. Over 40 percent are women.
  • Eight of SmiLe’s 20 alumni companies are listed on AktieTorget or Nasdaq First North.
  • The companies covers business areas such as therapy, diagnosis, drug delivery, stem-cells, medtech, nanotech, digital health, bio-greentech and expert research service.

Contact us at:; LinkedIn, Twitter and Facebook.


Semcon is an international technology company that develops products based on human needs and behaviours. We strengthen our customers’ competitiveness by always starting from the end user, because the person who knows most about the user’s needs creates the best products and the clearest benefits to humans. Semcon collaborates mainly with companies in the automotive, industry, energy and life science sectors. With more than 2000 specialised employees, Semcon has the ability to take care of the entire product development cycle, from strategy and technology development to design and product information.
Semcon was founded in Sweden in 1980 and has offices in over 30 locations in eight different countries. In 2016, the Group reported annual sales of SEK 1.8 billion. 

Roskilde University

Roskilde University is a public, research-driven university founded in 1972.

The University has 4 departments, 950 employees and 8,800 students.

Roskilde University builds on innovative and student-centred forms of learning, strong interdisciplinary research environments, and a shared focus on the great social, cultural, economic and environmental challenges in the world around us. The research aim to develop sustainable solutions to major challenges of the future, both nationally and globally. 


Probiotics have been part of the human diet for millennia and are found naturally in foods like pickled cucumbers, olives, sauerkraut, salami, yoghurt and sour milk. Many probiotic bacteria belong to the Lactobacillus or Bifidobacteriumgenuses. These are harmless and occur naturally in the gastrointestinal tract of humans and animals.


The composition of the gastrointestinal microflora is very important to our health. Disturbing the balance between “good” and “bad” bacteria may cause health problems and serious diseases. Probiotics help to balance the intestinal flora, which can result in a healthier digestive system and a strong immune system. As knowledge increases about how a better diet can prevent future medical problems, so too does the interest in probiotics.

We invite you to learn more about our probiotics and the research that supports them.

The World Health Organization defines probiotics as “live micro-organisms which, when administered in sufficient amounts, confer a health benefit on the host”.


SidekickHealth was founded by two practicing physicians, Tryggvi “Thor” Thorgeirsson, M.D., MPH, and Saemundur “Sam” Oddsson, M.D., to predict and prevent lifestyle-related diseases. Recognizing that traditional methods of counseling for lifestyle change were not effective enough to bring about the massive shift needed to reverse the global epidemic of chronic illness, these two founders brought together a team of physicians, psychologists, public health scientists, biomedical engineers and game developers, and drew on the latest research from leading academic and medical institutions in the U.S. and Europe. 

The result is SidekickHealth, a highly engaging, gamified service and app featuring programs for diet, physical activity and stress management. The platform is designed to reach those who are in greatest need of lifestyle change, including the 50 percent of adults who have low health literacy, and people with low motivation for lifestyle change. SidekickHealth also helps diabetes prevention programs and chronic disease management programs lower operational costs, improve outcomes and increase value-based reimbursements.



I Pfizer Danmark ønsker vi gennem vores sundhedsfaglige aktiviteter at bidrage til udviklingen af et stærkt dansk sundhedsvæsen. Det kan kun ske i dialog og samarbejde med relevante parter som læger, hospitaler, kommuner, regioner, politikere, medier m.fl.

Pfizers virksomhed i Danmark spænder over en bred vifte af sundhedsfaglige kompetencer, som danner det samlede billede af, hvad vi arbejder med.


AddLife is a group that comprises approximately 25 operating subsidiaries that mainly operates in the Nordic Life Science market. The Life Science market can be divided in larger market areas, where the group primarily focuses in selected niches in the market areas diagnostics, medical technology and biomedical research and laboratory analysis.  AddLife has operates in two business areas; Labtech and Medtech. The business area Labtech focuses on sales to the two market areas of diagnostics and biomedical research and laboratory analysis while Medtech focuses on sales to the market area medical technology. AddLife is, except from the operations in the Nordic countries, also represented by smaller businesses on the European market in Germany, the Benelux countries, Estonia and Italy.


Symphogen is a leading clinical stage antibody oncology-focused company with a differentiated monoclonal antibody, or mAb, mixture product pipeline with significant clinical potential and commercial opportunities. The company’s novel biologic approach is uniquely designed to address tumor diversity and resistance by combining multiple antibodies in a single drug product.

GAEU Consulting

GAEU Consulting has written the winning SME Instrument Phase 2 applications for the Swedish life science companies Immunovia, SymCel, Ilya Pharma, Scandinavian Biopharma, Verigraf, Idogen, Corline Biomedical, Senzagen, Opsis, Clinical Laserthermia Systems and Betagenon. GAEU Consulting is an EU grant consultancy specialized in the Horizon 2020 SME Instrument programme and other types of national and international public innovation funding. The firm combine high academic standards with strong business acumen. See complete reference list at our webpage 



Biokinetic Europe

BioKinetic Europe is an independently owned clinical research organisation (CRO). Established in 1996, BioKinetic has developed a reputation as a leading European early phase clinical pharmacology unit. BioKinetic has its primary operation in Belfast, Northern Ireland but with many of its Sponsors being based in the Medicon Valley region, they have established a secondary infrastructure in the greater Copenhagen area including a dedicated office space and selection of local CRAs.

BioKinetic’s core specialism lies in the design and meticulous conduct of adaptive study protocols (Phase I-III), from First-in-Man to Proof-of-Concept across a range of therapeutic areas including Diabetes, Women’s Health, Vaccines, Ophthalmology and Respiratory.

Their Phase I CPU in Belfast, Northern Ireland, which recently implemented a new Electronic Data Capture (EDC) system has held MHRA Supplementary Accreditation since 2009, a symbol that demonstrates their ongoing commitment to provide the industry’s highest standards of volunteer safety and data integrity. BioKinetic is an approved training unit for the Faculty of Pharmaceutical Medicine’s Diploma course with all Research Physicians enrolled on the programme.


Teknologisk Institut

The Life Science division at Danish Technological Institute (DTI) provides novel solutions to a wide range of obstacles in pharma, bio- and medtech.

At DTI the overall mission of Life Science is to challenge the status quo by inventing outstanding technological solutions in cooperation with clients, technology providers, hospitals, end-users, and universities.

Our Life Science division is rather unique as it gives our clients access to a range of platforms and technologies for testing, analysing, and characterization. We have specialists in physics, biology, chemistry, molecular biology, engineering, etc, who can find or develop the right solutions that are customised to meet the individual client´s needs and requirements.

We fx test coatings and materials using in vitro analyses, optimise cleaning procedures for reusable medical devices, test autoclaving systems for medical equipment, and validate products for improved wound treatment.

We are experienced in using genomics, transcriptomics, and proteomics data for applied R&D, e.g., when investigating infection and drug mechanisms and performing drug target deconvolution. We have also contributed significantly to the development of market-ready diagnostic assays for patient stratification.

The diversity of our competences reflects the great variation in the type of tasks and challenges that we can manage for life science.



PledPharma is a Swedish pharmaceutical company developing new drugs that protect the body against oxidative stress – a potentially disabling and sometimes life-threatening condition that can be caused by for example chemotherapy treatment or acetaminophen (paracetamol) overdose. The company’s most advanced project PledOx® reduces nerve damage associated with chemotherapy treatment. Positive results from phase IIb study PLIANT were presented in the spring of 2015 with follow-up and survival data presented during 2016. Phase III studies are planned to start during 2017. The drug candidate Aladote® is developed to reduce the risk of acute liver failure associated with acetaminophen overdose. Proof-of-principle clinical studies are planned to start 2017.

PledPharma (STO:PLED) is listed on Nasdaq First North

Agnitio A/S

Digital Customer Experience  – Technology Partner for the Global Life Science Industry

Agnitio A/S is specialized in the life science industry, partnering with the world’s leading pharmaceutical, medical device, consumer health and animal health companies.

With our innovative digital communication services & solutions, we have become a trusted and preferred partner with major life science companies like Amgen, Bayer, Philips, and Roche contributing to major successes on their digital transformation journey.

Agnitio A/S is able to accelerate your digital evolution generating strong customer insights and delivering a proven customer experience throughout the value chain. Agnitio A/S matches state of the art healthcare communication technology with professional services to activate and maximize the effectiveness of your Digital & Multichannel Sales & Marketing Strategy.



Medicollect is a service provider specialized in patient recruitment for clinical trials. We are offering faster, safer and more reliable supply of qualified and pre-screened patients for clinical trials within all diseases. Clients are pharma, biotech and CROs in Denmark, Sweden and the UK. Our clients avoid delays and costs of opening more sites. Medicollect operates large proprietary databases of volunteers and qualify patients for studies via own study nurses performing telephone pre-screening, which means low work burden for site teams and high probability of enrolment. Medicollect only charges a fixed price per randomised patient.


UL Compliance to Performance

For over 30 years, UL Compliance to Performance has provided solutions to many of the world’s leading Life Science companies. Our comprehensive compliance and quality management approach integrates technology, content and professional services, designed specifically to help clients in the Life Science Industry evolve from Compliance to Performance as they market their products to the US and the EU. We provide solutions based from a combination of advisory solutions delivered by local SME’s and a strong modular SaaS/Cloud technology platform that features ComplianceWire®, our 21 CFR and Annex 11-validated fully scalable Learning Management System. Our clients benefit from the same Learning Management Technology that we partner with the US FDA to train over 35,000 investigators globally.

UL is a premier global independent safety science company that has championed progress for 120 years. It’s more than 12,000 professionals are guided by the UL mission to promote safe working and living environments for all people.


NDA Group, the world’s leading drug development consultancy.

We support life science companies all over the world with the single aim to streamline the global development and commercialization process in order to accelerate patient access to important medical therapies.

NDA comprises over 150 dedicated consultants with industry and regulatory agency backgrounds, supported by a network of over 1 000 scientific, clinical, regulatory and drug development experts. Our advice covers all phases of development and all major therapeutic areas. With our support you can cut the time and cost it takes to get your product to the patients that need them.



Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time. The growing and increasingly aging world population requires improved medical care and an adequate supply of food. Bayer is improving people’s quality of life by preventing, alleviating and treating diseases. And we are helping to provide a reliable supply of high-quality food, feed and plant-based raw materials.

Health Capital Helsinki

Health Capital Helsinki is a leading European hub of life science and health tech research, knowledge and business. Our spearheads are neuro, cancer, digital health, future hospital, food, sustainability, and biodiversity.

The City of Helsinki, the University of Helsinki, Aalto University and HUS Helsinki University Hospital are developing a research based innovation and business ecosystem, with the aim of making Helsinki the leading European region of life science and health tech.


Immunitrack is specialized  in next generation MHC-peptide  technologies for best-in-class in vitro peptide immunogenicity assessment for optimized biologics, vaccines and immunotherapies. New ways of measuring and preparing MHC-peptide complex are provided to ensure cost-effective development of best-in-class biologic therapeutics.

Immunitrack was established in 2013, and its expertise has been validated through more than a decade of academic research.  Companies that already benefit from Immunitrack’s platform technology include notable top 20 pharmaceutical and biotech companies.

Sedermera Fondkommission

Sedermera Fondkommission offers services for listed companies or companies with the target of being listed at a trading platform. Sedermera’s services includes corporate finance, certified adviser, M&A’s, financial communications, issue management and market making. Sedermera is a secondary name of ATS Finans AB, an investment firm under the supervision of the Swedish FSA (Finansinspektionen). Sedermera’s headquarter is in Malmö, Sweden.

Aktie Torget

AktieTorget operates a marketplace since 1998 for the trading of shares and other financial instruments. Legally speaking, the marketplace a so-called multilateral trading facility (also called MTF). Operation of the trading platform is a type securities business under the Securities Market Act and AktieTorget’s operations are, therefore, under the supervision of Finansinspektionen (FI). Several Medicon Valley based life science companies are listed on AktieTorget.


MultiHelix AB is a company working in the intersection of life science, information and communication technology and food tech. We are a company with a strong mission to create value for people’s health and well being by utilising knowledge for sustainable growth and welfare. 

Head office London, UK

ISG is a dynamic global construction and engineering
services company. Specialised in fit out, technology,
construction and developments and dedicated to delivering
places that help people and businesses thrive.

London, UK

The Danish-UK Chamber of Commerce (DUCC) was founded on 23 August 1989 by the Danish Embassy and prominent business people in London, and was initially set up to enhance the Anglo-Danish marketplace through networking.

To this day, the DUCC’s core mission is “To promote business, trade and investment between Denmark, the UK and internationally”

We do this through events, monthly newsletters where we encourage our members to take an active part and sending us their contributions ie company news, press releases, event invitations, new employments.

The DUCC is a networking based non-profit organisation. To give members, companies and individuals an opportunity to network and benefit from each other, the Chamber is on average hosting 25-35 events throughout the year at which prominent speakers from the worlds of business and politics are invited. Topics are carefully selected to be of interest to the Danish, British and wider international business community.

DIS -Study Abroad in Scandinavia
Copenhagen, Denmark

DIS is a non-profit study abroad foundation established in Denmark in 1959, with locations in Copenhagen and Stockholm. DIS provides semester, academic year, and summer programs taught in English, and offers high-impact learning experiences for upper-division undergraduate students from distinguished North American colleges and universities. The intellectually challenging curriculum is broad, cutting edge, and enriched by experiential learning components, including faculty-led study tours across Europe. The housing and extracurricular offerings provide students with opportunities for meaningful cultural engagement and personal growth.